Orthofix Medical Inc. (OFIX)
USD 15.54
(-4.66%)
USD 15.54
(-4.66%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -139.11 Million USD | -585.76% |
| 2022 | -20.67 Million USD | -231.6% |
| 2021 | -6.23 Million USD | -485.77% |
| 2020 | 1.61 Million USD | -93.52% |
| 2019 | 24.94 Million USD | -17.12% |
| 2018 | 30.09 Million USD | -26.26% |
| 2017 | 40.81 Million USD | 93.72% |
| 2016 | 21.06 Million USD | 127.63% |
| 2015 | 9.25 Million USD | -45.99% |
| 2014 | 17.13 Million USD | 436.86% |
| 2013 | -5.08 Million USD | -105.72% |
| 2012 | 89.01 Million USD | 173.72% |
| 2011 | 32.51 Million USD | -63.46% |
| 2010 | 88.99 Million USD | 39.32% |
| 2009 | 63.87 Million USD | 124.86% |
| 2008 | -256.94 Million USD | -775.17% |
| 2007 | 38.05 Million USD | 329.88% |
| 2006 | 8.85 Million USD | -85.17% |
| 2005 | 59.7 Million USD | 8.56% |
| 2004 | 55 Million USD | 35.52% |
| 2003 | 40.58 Million USD | -5.48% |
| 2002 | 42.93 Million USD | 40.79% |
| 2001 | 30.49 Million USD | 34.21% |
| 2000 | 22.72 Million USD | -2.11% |
| 1999 | 23.21 Million USD | 51.74% |
| 1998 | 15.3 Million USD | 37.84% |
| 1997 | 11.1 Million USD | 68.18% |
| 1996 | 6.6 Million USD | -12.0% |
| 1995 | 7.5 Million USD | -35.34% |
| 1994 | 11.6 Million USD | 9.43% |
| 1993 | 10.6 Million USD | 27.71% |
| 1992 | 8.3 Million USD | -60.29% |
| 1991 | 20.9 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -21.73 Million USD | 22.83% |
| 2024 Q1 | -28.16 Million USD | -49.3% |
| 2023 Q1 | -55.58 Million USD | -533.75% |
| 2023 FY | -141.76 Million USD | -585.76% |
| 2023 Q2 | -36.63 Million USD | 34.09% |
| 2023 Q3 | -24.44 Million USD | 33.26% |
| 2023 Q4 | -18.86 Million USD | 22.84% |
| 2022 Q1 | -8.57 Million USD | 8.29% |
| 2022 Q3 | -5.37 Million USD | 26.04% |
| 2022 FY | -20.67 Million USD | -231.6% |
| 2022 Q2 | -7.26 Million USD | 15.31% |
| 2022 Q4 | -8.77 Million USD | -63.22% |
| 2021 FY | -6.23 Million USD | -485.77% |
| 2021 Q1 | -2.91 Million USD | -178.7% |
| 2021 Q2 | 4.26 Million USD | 246.33% |
| 2021 Q3 | -313 Thousand USD | -107.34% |
| 2021 Q4 | -9.35 Million USD | -2888.18% |
| 2020 Q3 | 4.17 Million USD | 119.88% |
| 2020 Q1 | 6.85 Million USD | 67.37% |
| 2020 Q4 | 3.7 Million USD | -11.26% |
| 2020 FY | 1.61 Million USD | -93.52% |
| 2020 Q2 | -21 Million USD | -406.39% |
| 2019 Q1 | -4.44 Million USD | -135.87% |
| 2019 Q2 | 451 Thousand USD | 110.14% |
| 2019 Q3 | -18.88 Million USD | -4286.7% |
| 2019 Q4 | 4.09 Million USD | 121.69% |
| 2019 FY | 24.94 Million USD | -17.12% |
| 2018 Q4 | 12.4 Million USD | 217.43% |
| 2018 FY | 30.09 Million USD | -26.26% |
| 2018 Q2 | 7.02 Million USD | -10.78% |
| 2018 Q3 | 3.9 Million USD | -44.38% |
| 2018 Q1 | 7.87 Million USD | -55.92% |
| 2017 Q1 | 5.91 Million USD | -20.19% |
| 2017 Q4 | 17.86 Million USD | 97.7% |
| 2017 Q3 | 9.03 Million USD | 12.95% |
| 2017 FY | 40.81 Million USD | 93.72% |
| 2017 Q2 | 7.99 Million USD | 35.12% |
| 2016 FY | 21.06 Million USD | 127.63% |
| 2016 Q4 | 7.41 Million USD | -20.01% |
| 2016 Q1 | 7.12 Million USD | -3.41% |
| 2016 Q3 | 9.27 Million USD | 451.44% |
| 2016 Q2 | -2.63 Million USD | -137.01% |
| 2015 Q3 | 4.13 Million USD | -16.01% |
| 2015 Q1 | -7.19 Million USD | -281.94% |
| 2015 FY | 9.25 Million USD | -45.99% |
| 2015 Q2 | 4.92 Million USD | 168.52% |
| 2015 Q4 | 7.38 Million USD | 78.3% |
| 2014 Q1 | 2.46 Million USD | 138.65% |
| 2014 Q4 | 3.95 Million USD | -39.26% |
| 2014 Q2 | 6.7 Million USD | 171.97% |
| 2014 FY | 17.13 Million USD | 436.86% |
| 2014 Q3 | 6.5 Million USD | -2.92% |
| 2013 Q3 | -15.6 Million USD | -277.19% |
| 2013 FY | -5.08 Million USD | -105.72% |
| 2013 Q4 | -6.37 Million USD | 59.12% |
| 2013 Q2 | 8.8 Million USD | 118.79% |
| 2013 Q1 | 4.02 Million USD | -83.56% |
| 2012 Q4 | 24.48 Million USD | 13.69% |
| 2012 FY | 89.01 Million USD | 173.72% |
| 2012 Q1 | 22.04 Million USD | 29.72% |
| 2012 Q2 | 20.56 Million USD | -6.71% |
| 2012 Q3 | 21.53 Million USD | 4.71% |
| 2011 FY | 32.51 Million USD | -63.46% |
| 2011 Q4 | 16.99 Million USD | -26.16% |
| 2011 Q2 | 18.57 Million USD | 171.26% |
| 2011 Q3 | 23.01 Million USD | 23.93% |
| 2011 Q1 | -26.06 Million USD | -254.75% |
| 2010 FY | 88.99 Million USD | 39.32% |
| 2010 Q4 | 16.84 Million USD | -11.34% |
| 2010 Q1 | 31.94 Million USD | 45.34% |
| 2010 Q2 | 21.21 Million USD | -33.6% |
| 2010 Q3 | 18.99 Million USD | -10.45% |
| 2009 Q4 | 21.97 Million USD | 23.82% |
| 2009 Q3 | 17.75 Million USD | 30.09% |
| 2009 Q1 | 10.5 Million USD | 11.23% |
| 2009 Q2 | 13.64 Million USD | 29.95% |
| 2009 FY | 63.87 Million USD | 124.86% |
| 2008 Q4 | 9.44 Million USD | 103.26% |
| 2008 Q1 | 11.59 Million USD | 239.75% |
| 2008 Q2 | 11.53 Million USD | -0.47% |
| 2008 FY | -256.94 Million USD | -775.17% |
| 2008 Q3 | -289.51 Million USD | -2609.47% |
| 2007 FY | 38.05 Million USD | 329.88% |
| 2007 Q4 | -8.29 Million USD | -152.52% |
| 2007 Q1 | 14.94 Million USD | 18.79% |
| 2007 Q3 | 15.79 Million USD | 1.11% |
| 2007 Q2 | 15.61 Million USD | 4.52% |
| 2006 Q2 | 15.07 Million USD | 29.25% |
| 2006 FY | 8.85 Million USD | -85.17% |
| 2006 Q4 | 12.57 Million USD | 141.3% |
| 2006 Q1 | 11.66 Million USD | -11.73% |
| 2006 Q3 | -30.45 Million USD | -302.09% |
| 2005 Q2 | 16.57 Million USD | 6.14% |
| 2005 FY | 59.7 Million USD | 8.56% |
| 2005 Q4 | 13.2 Million USD | -4.35% |
| 2005 Q3 | 13.81 Million USD | -16.66% |
| 2005 Q1 | 15.61 Million USD | 8.32% |
| 2004 Q1 | 12.78 Million USD | 10.3% |
| 2004 Q3 | 14.59 Million USD | 10.57% |
| 2004 Q2 | 13.2 Million USD | 3.23% |
| 2004 Q4 | 14.41 Million USD | -1.27% |
| 2004 FY | 55 Million USD | 35.52% |
| 2003 Q3 | 8.82 Million USD | -15.3% |
| 2003 FY | 40.58 Million USD | -5.48% |
| 2003 Q1 | 9.74 Million USD | -11.11% |
| 2003 Q2 | 10.42 Million USD | 6.95% |
| 2003 Q4 | 11.59 Million USD | 31.37% |
| 2002 Q3 | 10.5 Million USD | -7.17% |
| 2002 Q1 | 10.15 Million USD | 111.43% |
| 2002 Q2 | 11.31 Million USD | 11.4% |
| 2002 FY | 42.93 Million USD | 40.79% |
| 2002 Q4 | 10.96 Million USD | 4.34% |
| 2001 Q4 | -88.86 Million USD | -321.28% |
| 2001 Q3 | 40.15 Million USD | 434.66% |
| 2001 Q1 | 7.58 Million USD | 80.35% |
| 2001 Q2 | 7.51 Million USD | -0.94% |
| 2001 FY | 30.49 Million USD | 34.21% |
| 2000 Q1 | 6.34 Million USD | -2.64% |
| 2000 Q4 | 4.2 Million USD | -28.33% |
| 2000 Q3 | 5.86 Million USD | -7.05% |
| 2000 FY | 22.72 Million USD | -2.11% |
| 2000 Q2 | 6.31 Million USD | -0.52% |
| 1999 FY | 23.21 Million USD | 51.74% |
| 1999 Q2 | 5.5 Million USD | 0.0% |
| 1999 Q4 | 6.51 Million USD | 14.32% |
| 1999 Q3 | 5.7 Million USD | 3.64% |
| 1999 Q1 | 5.5 Million USD | 108.93% |
| 1998 Q3 | 26.4 Million USD | 3.53% |
| 1998 FY | 15.3 Million USD | 37.84% |
| 1998 Q4 | -61.6 Million USD | -333.33% |
| 1998 Q1 | 25 Million USD | 145.7% |
| 1998 Q2 | 25.5 Million USD | 2.0% |
| 1997 Q2 | 22.4 Million USD | 8.74% |
| 1997 FY | 11.1 Million USD | 68.18% |
| 1997 Q4 | -54.7 Million USD | -339.91% |
| 1997 Q3 | 22.8 Million USD | 1.79% |
| 1997 Q1 | 20.6 Million USD | 140.71% |
| 1996 Q3 | 19.2 Million USD | 1.05% |
| 1996 Q4 | -50.6 Million USD | -363.54% |
| 1996 Q2 | 19 Million USD | 0.0% |
| 1996 FY | 6.6 Million USD | -12.0% |
| 1996 Q1 | 19 Million USD | 167.86% |
| 1995 FY | 7.5 Million USD | -35.34% |
| 1995 Q4 | -28 Million USD | -325.81% |
| 1995 Q1 | 3.3 Million USD | 119.41% |
| 1995 Q2 | 11.6 Million USD | 251.52% |
| 1995 Q3 | 12.4 Million USD | 6.9% |
| 1994 Q4 | -17 Million USD | -275.26% |
| 1994 Q2 | 2.7 Million USD | -70.97% |
| 1994 Q1 | 9.3 Million USD | 176.23% |
| 1994 FY | 11.6 Million USD | 9.43% |
| 1994 Q3 | 9.7 Million USD | 259.26% |
| 1993 Q4 | -12.2 Million USD | -269.44% |
| 1993 FY | 10.6 Million USD | 27.71% |
| 1993 Q3 | 7.2 Million USD | -6.49% |
| 1993 Q2 | 7.7 Million USD | -1.28% |
| 1993 Q1 | 7.8 Million USD | 162.9% |
| 1992 Q1 | 7.1 Million USD | 33.96% |
| 1992 FY | 8.3 Million USD | -60.29% |
| 1992 Q4 | -12.4 Million USD | -279.71% |
| 1992 Q3 | 6.9 Million USD | 4.55% |
| 1992 Q2 | 6.6 Million USD | -7.04% |
| 1991 Q3 | 5.2 Million USD | 0.0% |
| 1991 FY | 20.9 Million USD | 0.0% |
| 1991 Q1 | 5.2 Million USD | 0.0% |
| 1991 Q2 | 5.2 Million USD | 0.0% |
| 1991 Q4 | 5.3 Million USD | 1.92% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -868.665% |
| Cerus Corporation | -30.05 Million USD | -362.882% |
| OrthoPediatrics Corp. | -25.76 Million USD | -439.898% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -1209.722% |
| Talis Biomedical Corporation | -66.81 Million USD | -108.202% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -704.29% |
| Inogen, Inc. | -109.38 Million USD | -27.173% |
| Spectral AI, Inc. | -12.98 Million USD | -971.396% |
| Nano-X Imaging Ltd. | -62.58 Million USD | -122.26% |
| CVRx, Inc. | -43.1 Million USD | -222.739% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -3843.027% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -1019.327% |
| Venus Concept Inc. | -28.3 Million USD | -391.398% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | -157.478% |
| Bioventus Inc. | -81.72 Million USD | -70.217% |
| BrainsWay Ltd. | -4.92 Million USD | -2723.422% |
| Envoy Medical, Inc. | -18.37 Million USD | -657.226% |
| electroCore, Inc. | -18.8 Million USD | -639.75% |
| IceCure Medical Ltd | -15.57 Million USD | -793.105% |
| Lucid Diagnostics Inc. | -48.48 Million USD | -186.931% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -705.593% |
| MaxCyte, Inc. | -48.29 Million USD | -188.018% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -1063.589% |
| Nexalin Technology, Inc. | -5.69 Million USD | -2342.113% |
| PAVmed Inc | -68.79 Million USD | -102.209% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | -145.938% |
| RxSight, Inc. | -50.08 Million USD | -177.748% |
| Sight Sciences, Inc. | -57.27 Million USD | -142.885% |
| SI-BONE, Inc. | -46.93 Million USD | -196.414% |
| TELA Bio, Inc. | -44.07 Million USD | -215.621% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | -156.898% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | -170.495% |
| LivaNova PLC | -68.49 Million USD | -103.086% |
| 908 Devices Inc. | -42.75 Million USD | -225.343% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 19.773% |
| Nemaura Medical Inc. | -9.59 Million USD | -1349.782% |
| NeuroPace, Inc. | -27.17 Million USD | -411.923% |
| LENSAR, Inc. | -12.22 Million USD | -1037.542% |
| Apyx Medical Corporation | -17.25 Million USD | -706.014% |
| Cutera, Inc. | -156.23 Million USD | 10.958% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -1516.806% |
| BioSig Technologies, Inc. | -28.51 Million USD | -387.9% |
| Anika Therapeutics, Inc. | -87.63 Million USD | -58.731% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -519.754% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 224.733% |
| Axonics, Inc. | -26.05 Million USD | -433.868% |
| Outset Medical, Inc. | -169.77 Million USD | 18.06% |
| IRIDEX Corporation | -10 Million USD | -1290.127% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | -27.425% |
| IRadimed Corporation | 20.03 Million USD | 794.319% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -1587.205% |
| INVO Bioscience, Inc. | -6.76 Million USD | -1955.664% |
| Telesis Bio, Inc. | -35.15 Million USD | -295.761% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 1070.761% |
| Varex Imaging Corporation | 32.1 Million USD | 533.364% |
| Quipt Home Medical Corp. | 3.91 Million USD | 3649.63% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -1046.542% |
| Pulmonx Corporation | -61.93 Million USD | -124.606% |
| Dynatronics Corporation | -2.27 Million USD | -6019.976% |
| Modular Medical, Inc. | -17.52 Million USD | -693.599% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -850.27% |
| Semler Scientific, Inc. | 22.25 Million USD | 725.045% |
| InMode Ltd. | 195.66 Million USD | 171.098% |
| Bruker Corporation | 436.9 Million USD | 131.84% |
| Cytosorbents Corporation | -31.2 Million USD | -345.733% |
| DexCom, Inc. | 597.7 Million USD | 123.274% |
| Align Technology, Inc. | 643.33 Million USD | 121.623% |
| Viveve Medical, Inc. | -21.55 Million USD | -545.432% |
| ZimVie Inc. | -30.93 Million USD | -349.627% |
| Movano Inc. | -29.69 Million USD | -368.542% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -399.587% |
| Nexalin Technology, Inc. | -5.69 Million USD | -2342.113% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -3843.027% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 40.355% |
| Profound Medical Corp. | -28.61 Million USD | -386.127% |
| Insulet Corporation | 220 Million USD | 163.232% |
| enVVeno Medical Corporation | -25.23 Million USD | -451.193% |
| Surmodics, Inc. | -5.64 Million USD | -2364.305% |
| iCAD, Inc. | -7.68 Million USD | -1709.208% |
| Nuwellis, Inc. | -17.63 Million USD | -689.053% |
| Biotricity, Inc. | -8.82 Million USD | -1475.734% |
| iRhythm Technologies, Inc. | -125.16 Million USD | -11.145% |
| Aethlon Medical, Inc. | -12.63 Million USD | -1000.853% |
| InspireMD, Inc. | -21.14 Million USD | -557.948% |
| PAVmed Inc. | -68.79 Million USD | -102.209% |
| BIOLASE, Inc. | -17.93 Million USD | -675.548% |
| Beyond Air, Inc. | -63 Million USD | -120.788% |
| FONAR Corporation | 16.53 Million USD | 941.288% |
| AxoGen, Inc. | -21.46 Million USD | -548.169% |
| Vivani Medical, Inc. | -26.96 Million USD | -415.891% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 871.077% |
| Inari Medical, Inc. | -14.03 Million USD | -891.377% |
| UFP Technologies, Inc. | 57.66 Million USD | 341.242% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -2723.078% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -2106.075% |
| Tenon Medical, Inc. | -15.72 Million USD | -784.53% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -1761.252% |
| Co-Diagnostics, Inc. | -42.7 Million USD | -225.737% |
| AdaptHealth Corp. | -598.4 Million USD | 76.753% |
| Sintx Technologies, Inc. | -13.35 Million USD | -941.398% |
| NanoVibronix, Inc. | -3.43 Million USD | -3948.603% |
| Quanterix Corporation | -49.7 Million USD | -179.894% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -1046.542% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -36316.23% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 58.408% |
| TransMedics Group, Inc. | -28.72 Million USD | -384.248% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -489.15% |
| NeuroMetrix, Inc. | -7.15 Million USD | -1845.181% |
| Hyperfine, Inc. | -48.11 Million USD | -189.12% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | -113.93% |
| Biomerica, Inc. | -6.36 Million USD | -2084.859% |
| Bone Biologics Corporation | -9.42 Million USD | -1375.451% |
| AVITA Medical, Inc. | -40.4 Million USD | -244.314% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -1249.113% |
| Silk Road Medical, Inc | -59.27 Million USD | -134.702% |